Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.4% Today

What is Teladoc Health Inc.?

Teladoc Health (TDOC) is a leading telehealth provider that offers remote consultations with healthcare professionals, gaining attention for its innovative healthcare services, particularly during the pandemic.

Why is Teladoc Health Inc. going down?

TDOC stock is down 5.4% on Mar 11, 2026 16:15

• Teladoc Health's stock faced downward pressure today, despite positive developments and upgrades from analysts.
• Investor sentiment was dampened by the company's conservative outlook for upcoming periods and pessimistic earnings per share guidance for Q1 and FY2026.
• Analysts gave mixed reviews, with some raising the stock's rating based on valuation and potential exit strategies, while others remained wary of market saturation and long-term challenges.
• Following the analyst upgrades, the initial spike in share price may have been brief, as market sentiment continues to be uncertain, driven by apprehensions about profitability and insider trading activity.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Why Teladoc (TDOC) Stock Is Up Today

Teladoc Health (NYSE:TDOC) shares rose 4.4% after Deutsche Bank upgraded the stock to Buy from Hold, setting a $11 price target. The upgrade cited the telehealth provider's low valuation and plans to restructure its BetterHelp unit. This positive outlook follows strong fourth-quarter results that surpassed analyst expectations, though the company provided a cautious forecast for the year ahead.

https://finviz.com/news/335801/why-teladoc-tdoc-stock-is-up-today

Teladoc Health Stock Pops - Here's Why

Teladoc Health Inc. (NYSE:TDOC) shares rose after the company reported stronger-than-expected quarterly results, despite a cautious outlook for future periods. While some analysts, like Deutsche Bank, upgraded the stock based on valuation and potential exit scenarios, others maintained a cautious stance due to a saturated market. The stock shows short-term technical strength but long-term struggles, trading above its 20-day SMA but below its 100-day SMA.

https://www.bitget.com/amp/news/detail/12560605253519

Teladoc Health (NYSE:TDOC) Shares Gap Up After Analyst Upgrade

Teladoc Health (NYSE:TDOC) shares gapped up after Deutsche Bank upgraded the stock from a "hold" to a "buy" rating with an $11 price target. This comes despite Teladoc beating Q4 earnings estimates but remaining unprofitable and issuing negative EPS guidance for Q1 and FY2026. Market sentiment is mixed, with institutional investors holding a significant portion of shares, while insiders have recently sold some.

https://www.marketbeat.com/instant-alerts/teladoc-health-nysetdoc-shares-gap-up-after-analyst-upgrade-2026-03-10/

Gcc Telemedicine Market Is Going to Boom Rapidly | Teladoc Health Inc., American Well Corporation

The GCC Telemedicine Market is projected for rapid growth from 2026 to 2033, driven by various market patterns and factors. A new research study by Coherent Market Insights Pvt. Ltd. examines this expansion, segmenting the market by type, application, and region. Key players include Teladoc Health Inc., American Well Corporation, and Philips Healthcare, with the report offering detailed insights into market dynamics, competitive analysis, and regional overviews for strategic decision-making.

https://www.openpr.com/news/4419083/gcc-telemedicine-market-is-going-to-boom-rapidly-teladoc-health

Speech Therapy Market Is Going to Boom Rapidly | Teladoc Health • Amwell • Daxor Corporation • Talkspace

Coherent Market Insights has released a comprehensive report on the Speech Therapy Market, detailing industry trends, growth opportunities, and a forecast for 2026-2033. The report analyzes market competition, geographic distribution, and potential, providing insights for entrepreneurs, investors, and business strategists. Key players identified include Teladoc Health, Amwell, Daxor Corporation, and Talkspace, with market segmentation covering pediatric, adult, telepractice, and in-person speech therapy across various settings.

https://www.openpr.com/news/4416943/speech-therapy-market-is-going-to-boom-rapidly-teladoc-health

Trending Today

Mosaic Company (The) ($MOS) Stock Forecast: Down 9.3% Today

QuantumScape Corp. ($QS) Stock Forecast: Down 5.5% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 5.4% Today

Peloton Interactive Inc ($PTON) Stock Forecast: Down 5.7% Today

Kimco Realty Corporation ($KIM) Stock Forecast: Down 3.5% Today

SL Green Realty Corp ($SLG) Stock Forecast: Down 5.2% Today

StoneCo Ltd. ($STNE) Stock Forecast: Down 5.2% Today

Cleveland-Cliffs Inc. ($CLF) Stock Forecast: Down 5.0% Today

American Airlines Group Inc. ($AAL) Stock Forecast: Down 5.4% Today

TKO Group Holdings Inc ($TKO) Stock Forecast: Down 5.2% Today

Teladoc Health Inc. Price History

13.01.2026 - TDOC Stock was up 6.8%

• TDOC stock experienced a bullish movement today, likely driven by positive developments and partnerships in the telehealth industry.
• The announcement of the retirement of a long-serving board director may have been perceived positively by investors, signaling potential for new perspectives and growth opportunities within the company.
• The expansion of virtual care access through the HealthKey partnership underscores Teladoc Health's commitment to addressing healthcare disparities, which could have boosted investor confidence in the company's long-term vision and growth prospects.
• The bullish market movement for TDOC aligns with the overall positive outlook for the telemedicine sector, as highlighted by the projected significant growth of the global telemedicine and digital health markets in the coming years.

10.02.2026 - TDOC Stock was up 10.3%

• Teladoc Health's stock saw a strong bullish movement today.
• An inducement award to Daniel Conroy, the new Chief Growth Officer, U.S. Group Health, was announced under NYSE Rule 303A.08, potentially boosting investor confidence in the company's growth.
• The award, comprising restricted stock units and performance stock units tied to three-year targets, aligns Conroy's compensation with Teladoc's growth strategies, highlighting a focus on market expansion and financial performance.
• Despite a recent increase in short interest, Teladoc Health's positive developments and strategic initiatives appear to have outweighed any concerns, driving the bullish market activity.

06.01.2026 - TDOC Stock was up 5.1%

• Teladoc Health's strong bullish movement today could be attributed to the positive sentiment surrounding its efforts to enhance hypertension care through telemedicine services, showcasing its commitment to improving patient outcomes.
• The upcoming announcement of Teladoc Health's fourth-quarter 2025 financial results might have sparked investor optimism, leading to increased buying activity and driving the stock higher.
• Despite recent price drops and concerns about lacklustre performance, the market may be reacting positively to the potential growth opportunities in the digital therapeutics industry, where Teladoc Health plays a significant role.
• Jim Cramer's bearish outlook on Teladoc Health, citing reasons to sell the stock, could have initially caused some uncertainty; however, the market's response today indicates a divergence from this sentiment, potentially driven by a focus on the company's innovative healthcare solutions and future growth prospects.

19.01.2026 - TDOC Stock was up 5.6%

• Teladoc Health (TDOC) experienced a strong bullish movement today, likely driven by positive market sentiment and potential growth opportunities in its U.S. Integrated Care segment.
• Concerns were raised about peer multiple compression and soft Sensor Tower trends impacting revenue expectations, but the appointment of experienced executive Michael Smith to the board of directors may have instilled confidence in the company's long-term strategic focus and growth prospects.
• The market may be reacting positively to the anticipation of Teladoc's Q4 2025 earnings report, with analysts expecting growth in members and adjusted EBITDA in the U.S. Integrated Care segment, potentially offsetting declines in other areas.
• Despite price target reductions from various financial institutions due to industry challenges, the overall outlook for Teladoc Health remains positive, especially with a focus on innovation in virtual care and strategic transformations aligning with the company's mission.

27.01.2026 - TDOC Stock was down 5.2%

• Teladoc Health (TDOC) witnessed a strong bearish movement despite recent positive developments and financial improvements.
• The bullish upgrade by BofA Securities and narrowing Q4 losses suggested future profitability, but caution from analysts and multiple price target reductions affected the stock.
• Analysts' conflicting signals, with some cutting forecasts despite solid financial performance, led to investor uncertainty and a bearish market trend.
• Challenges in the BetterHelp segment and declining U.S. revenues likely impacted the negative sentiment, despite positive international growth and cost-saving efforts.

12.01.2026 - TDOC Stock was down 5.0%

• The collaboration with HealthKey indicates Teladoc Health's dedication to reducing healthcare disparities through extended virtual care access. However, market reaction possibly reflects worries about heightened competition and potential margin challenges.
• Positive growth forecasts for telemedicine and digital health sectors suggest a promising industry outlook. Nonetheless, stock performance of TDOC might be impacted by general market trends or company-specific issues.
• The decrease in Hims & Hers Health Inc. (HIMS) stock and advice to lower exposure could signal cautiousness towards telehealth firms, potentially influencing TDOC's stock performance.
• Despite optimistic industry growth forecasts, concerns about regulatory reviews on specific medications and competitive pressures outlined elsewhere might have raised worries among investors regarding TDOC's future profitability and market standing. This could have contributed to the observed bearish market movement today.

11.01.2026 - TDOC Stock was down 9.2%

• Today's decline in TDOC's stock price could be attributed to profit-taking by investors following a period of increased bullish activity in the options market.
• Concerns about Teladoc's financial health, including negative ROE and financial distress indicators, may have contributed to the stock's downward pressure despite positive long-term growth prospects for the telemedicine industry.
• The market response may be tied to valuation metrics indicating that TDOC's stock is currently trading near historical lows for its price-to-sales and price-to-book ratios, prompting questions about its current valuation and potential future growth.
• Despite the overall positive outlook for the telehealth market and the innovation and growth driven by key players, individual company performance and financial metrics like those of Teladoc can still impact short-term stock movements.

05.01.2026 - TDOC Stock was down 5.6%

• Teladoc Health's stock faced a significant bearish trend today, which could have been influenced by:
• Negative remarks by Jim Cramer, suggesting investors to sell due to fierce competition in the virtual medical care industry and more lucrative opportunities in AI stocks.
• Substantial stock price declines in the last month and year, indicating diminished investor confidence and future growth prospects.
• Despite being listed as one of the 2021 TIME100 Most Influential Companies, concerns about Teladoc's future competitiveness in the telehealth sector might be impacting its stock performance.
• The perception shift of Teladoc as an infrastructure investment rather than a high-growth stock, potentially undermining investor faith in the company's ability to deliver swift returns.

26.01.2026 - TDOC Stock was up 12.4%

• Teladoc Health's stock saw significant upward movement today, possibly driven by overall positive sentiment following the company's Q4 2025 results surpassing analyst expectations.
• Despite exceeding revenue projections and showing positive adjusted EBITDA, the stock initially showed little change post-earnings report. This could be due to concerns stemming from weaker-than-anticipated guidance for Q1 CY2026 revenue, as well as EPS and EBITDA for the whole of 2026.
• The rise in Teladoc Health's stock price after hours, preceding its upcoming earnings report on February 25, 2026, suggests short-term trader positioning and optimism despite ongoing net losses and a year-to-date weakness.
• Price target reductions by BofA Securities and Goldman Sachs in January 2026 might have initially impacted investor confidence negatively. However, today's positive market movement indicates a resurgence of interest in the company's potential for long-term growth.

03.01.2026 - TDOC Stock was down 8.5%

• Teladoc Health (TDOC) faced a strong bearish trend, declining 13.9% due to Medicare's decision to restrict telehealth coverage, particularly in rural areas and for specific mental health services. Concerns arose about decreasing BetterHelp users, rising competition, and the company's path to profitability.
• Despite being undervalued, regulatory uncertainties stemming from Medicare policy adjustments and potential impacts on earnings resulting from BetterHelp's revenue model transition are major factors influencing market skepticism and the decline in TDOC stock.
• Teladoc Health's CEO is prioritizing sustainable long-term growth and implementing strategic initiatives like broadening insurance acceptance for BetterHelp and targeted mergers and acquisitions to address some apprehensions. Nevertheless, investor sentiment remains dampened by the uncertainties surrounding reimbursement modifications and competitive dynamics.
• Today's notable bearish movement in Teladoc Health's stock can be attributed to a mix of regulatory hurdles, competitive pressures, and the necessity for clear implementation of growth strategies amidst market ambiguities.

27.00.2026 - TDOC Stock was down 5.1%

• Despite offering free non-emergency care to Texans affected by the recent winter storm, Teladoc Health (TDOC) experienced a strong bearish movement in the market.
• Investor caution and concerns about user trends and profitability have led to significant share price declines over the past year, even though the stock is trading at a notable discount to its intrinsic value and analyst targets.
• The company's recent upgrades to its 24/7 Care service, including expanded virtual urgent care and specialist input, have not been sufficient to offset the market's worries about future growth concerns and chronic care contracts.
• While Teladoc's data-driven expansion strategy aims to solidify its position in virtual care competition, challenges like weak user growth and ongoing losses continue to weigh on the stock's performance, leaving investors cautious about its long-term prospects.

11.02.2026 - TDOC Stock was down 5.4%

• Teladoc Health's stock faced downward pressure today, despite positive developments and upgrades from analysts.
• Investor sentiment was dampened by the company's conservative outlook for upcoming periods and pessimistic earnings per share guidance for Q1 and FY2026.
• Analysts gave mixed reviews, with some raising the stock's rating based on valuation and potential exit strategies, while others remained wary of market saturation and long-term challenges.
• Following the analyst upgrades, the initial spike in share price may have been brief, as market sentiment continues to be uncertain, driven by apprehensions about profitability and insider trading activity.